# Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

> **NCT07359105** · NA · RECRUITING · sponsor: **Sin Gon Kim** · enrollment: 2186 (estimated)

## Conditions studied

- Dyslipidemia Associated With Type II Diabetes Mellitus

## Interventions

- **DRUG:** Moderate-intensity statin monotherapy
- **DRUG:** Ezetimibe or ezetimibe-statin combination therapy

## Key facts

- **NCT ID:** NCT07359105
- **Lead sponsor:** Sin Gon Kim
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-09
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 2186 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07359105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07359105, "Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07359105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*